A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
* These authors contributed equally
Small bowel transplantation has become an accepted treatment option for patients with irreversible intestinal failure. Our experimental model of orthotopic small bowel transplantation in rats serves as a reliable tool to address underlying immunologic and inflammatory processes that complicate intestinal transplantation.
Small bowel transplantation has become an accepted clinical option for patients with short gut syndrome and failure of parenteral nutrition (irreversible intestinal failure). In specialized centers improved operative and managing strategies have led to excellent short- and intermediate term patient and graft survival while providing high quality of life 1,3. Unlike in the more common transplantation of other solid organs (i.e. heart, liver) many underlying mechanisms of graft function and immunologic alterations induced by intestinal transplantation are not entirely known6,7. Episodes of acute rejection, sepsis and chronic graft failure are the main obstacles still contributing to less favorable long term outcome and hindering a more widespread employment of the procedure despite a growing number of patients on home parenteral nutrition who would potentially benefit from such a transplant. The small intestine contains a large number of passenger leucocytes commonly referred to as part of the gut associated lymphoid system (GALT) this being part of the reason for the high immunogenity of the intestinal graft. The presence and close proximity of many commensals and pathogens in the gut explains the severity of sepsis episodes once graft mucosal integrity is compromised (for example by rejection). To advance the field of intestinal- and multiorgan transplantation more data generated from reliable and feasible animal models is needed. The model provided herein combines both reliability and feasibility once established in a standardized manner and can provide valuable insight in the underlying complex molecular, cellular and functional mechanisms that are triggered by intestinal transplantation. We have successfully used and refined the described procedure over more than 5 years in our laboratory 8-11. The JoVE video-based format is especially useful to demonstrate the complex procedure and avoid initial pitfalls for groups planning to establish an orthotopic rodent model investigating intestinal transplantation.
1. Donor Operation
2. Backtable Procedure
Immediately after extracting the graft, the aortic conduit is used for perfusion with 3 ml chilled UW solution. For this, a 20 G i.v. catheter on a 10 ml syringe is used. The perfusate should be observed to flow out freely from the divided portal vein. For the intestinal irrigation with Nebacetin, a 50 ml syringe is used.
3. Recipient Operation
Normal postoperative course
The transplanted animals should recover quickly from the procedure under a heat lamp for approximately 1 hr. Hypothermia is a major cause of postoperative mortality and should be carefully avoided intra- and postoperatively. Intraoperative fluid losses must be replaced by s.c. injection of 2.5 ml normal saline plus 2.5 ml Glucose 5% every 8 hr for the first 24 hr. The rats should also have free access to glucose solution (or gel diet) and water p.o. for the first 24 hr...
While intestinal transplant models in rats have been described as early as in the 1970ies 5 most of the recently employed models involve heterotopic intestinal transplantation using different techniques 13. While the heterotopic procedures in general have the advantage of easier microsurgical techniques and easier accessibility of the graft for assessment, heterotopic intestinal transplantation has the big disadvantage of not taking into account the multiple interactions of the transplanted s...
No conflicts of interest declared.
Name | Company | Catalog Number | Comments |
University of Wisconsin (UW) solution (ViaSpan) | Bristol-Myers Squibb | ||
Uro-Nebacetin N solution | Nycomed | 6967855 | |
Ampicillin | Ratiopharm | ||
Carprofen (Rimadyl) | Pfizer | ||
Prolene 10-0 unresorbable suture | Ethicon | ||
Monocryl 6-0 resorbable suture | Ethicon | ||
Vicryl 3-0 resorbable suture | Ethicon | ||
i.v. Catheter G 20 1.1x33 mm | Braun | ||
i.v. Catheter G 22 0.9x25 mm | Braun | ||
Kodan Skin Prep | Schülke | ||
NaCl 0.9% Infusion solution | Braun | ||
Curved forceps small | FineScienceTools | 11009-13 | |
Micro forceps curved | AESCULAP | BD 333 | |
Micro forceps curved | AESCULAP | FD281R | |
Micro forceps straight 1 | WPI | 5 | |
Micro forceps straight 2 | WPI | 2 | |
Micro needle holder | WPI | 14081 | |
Micro scissors | FineScienceTools | 15006-09 | |
Micro scalpel | MANI | Ophthalmic knife | |
Micro clamps | AESCULAP | FB329R |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved